THYROID GLAND PAPILLARY CARCINOMA
Clinical trials for THYROID GLAND PAPILLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND PAPILLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND PAPILLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost Cancer-Killing power of radiation
Disease control Recruiting nowThis study is testing whether taking two oral drugs (vemurafenib and cobimetinib) before standard radioactive iodine treatment can improve outcomes for patients with high-risk thyroid cancer that has a specific genetic change (BRAFV600E mutation). The goal is to see if these drug…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC
-
New scan could spot hidden thyroid cancer better
Diagnosis Recruiting nowThis study is testing a new type of PET/CT scan using a tracer called F-18 TFB to see if it can find recurrent or spreading thyroid cancer more accurately than current standard scans. Researchers will enroll 24 adults with papillary or follicular thyroid cancer who are already sc…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 09, 2026 14:25 UTC